Scientists at NYU have created a drug that targets cancer-causing HER2 mutations without harming healthy cells. This new ...

Antibodies show promise as candidates for therapeutics as well as tools for advancing mechanistic studies of the HER family receptors.

A previvor is essentially someone who has a genetic predisposition to certain cancers, but who may or may not currently have ...

For some proteins, a single mutation, or change in its DNA instructions, is all it takes to tip the balance between functioning normally and causing cancer. But despite causing major disease, these ...

An immune protein could hold the key to developing new drugs to help fight bowel cancer, according to new research from The ...

The past decade has witnessed a rapid expansion of genetic tests, including new instruments to inform patients who have been ...

This story is brought to you by Eastern Idaho Regional Medical Center, the largest medical facility in the region, serving ...

Researchers have mapped the genetic landscape of cancer drug resistance, uncovering that DNA changes can be grouped into four main categories and highlighting possible new therapeutic targets.

Researchers obtain detailed picture of the specific mechanisms by which each individual mutation studied impacts drug response.

Wolpin’s team used AI to find patterns in over nine million patients, looking at medical records, family history and genetic ...

All cancer mutations that cause drug resistance fall into one of four categories. New research has detailed each type, helping to uncover targets for drug development and identify potential ...

There isn’t a single answer to what causes pancreatic cancer because it involves multiple factors. Here’s what science knows ...